Taken together, these results indicated that TNFα-mediated PANX1 cleavage to promote ATP release may enhance cancer immunogenicity and promote chemotherapy-induced antitumor immunity by recruiting DCs and T cells to eradicate tumor cells. The gene discussed is TNF; the disease is neoplasm.